Quinine-induced renal failure as a result of rhabdomyolysis, haemolytic uraemic syndrome and disseminated intravascular coagulation

被引:11
作者
Lim, AKH
Ho, L
Levidiotis, V
机构
[1] Austin Hlth, Dept Nephrol, Heidelberg, Vic 3084, Australia
[2] Austin Hlth, Dept Pharm, Heidelberg, Vic, Australia
关键词
quinine; rhabdomyolysis; haemolytic uraemic syndrome; disseminated intravascular coagulation; atorvastatin; cytochrome P450;
D O I
10.1111/j.1445-5994.2006.01104.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This report describes a case of quinine-induced acute renal failure as a result of a combination of haemolytic uraemic syndrome and rhabdomyolysis with disseminated intravascular coagulation. The abrupt onset of symptoms occurred after ingestion of 300 mg of quinine along with atorvastatin. The patient recovered with supportive management, suggesting that plasma exchange may not be necessary in this situation. The possibility of a drug interaction contributing to rhabdomyolysis is raised. The proposed mechanism is through quinine inhibition of the cytochrome P450 isoenzyme 3A4, which may increase systemic levels of atorvastatin by reducing its first-pass metabolism.
引用
收藏
页码:465 / 467
页数:3
相关论文
共 10 条
[1]  
*ADRAC, 2005, ADV DRUG REACT ADV C
[2]   QUININE-INDUCED IMMUNE THROMBOCYTOPENIA WITH HEMOLYTIC-UREMIC SYNDROME - CLINICAL AND SEROLOGICAL FINDINGS IN 9 PATIENTS AND REVIEW OF LITERATURE [J].
GOTTSCHALL, JL ;
NEAHRING, B ;
MCFARLAND, JG ;
WU, GG ;
WEITEKAMP, LA ;
ASTER, RH .
AMERICAN JOURNAL OF HEMATOLOGY, 1994, 47 (04) :283-289
[3]   Comparative pharmacokinetic interaction profiles of pravastatin, simvastatin, and atorvastatin when coadministered with cytochrome P450 inhibitors [J].
Jacobson, TA .
AMERICAN JOURNAL OF CARDIOLOGY, 2004, 94 (09) :1140-1146
[4]   Quinine-induced disseminated intravascular coagulation: case report and review of the literature [J].
Knower, MT ;
Bowton, DL ;
Owen, J ;
Dunagan, DP .
INTENSIVE CARE MEDICINE, 2003, 29 (06) :1007-1011
[5]   Quinine-associated thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: Frequency, clinical features, and long-term outcomes [J].
Kojouri, K ;
Vesely, SK ;
George, JN .
ANNALS OF INTERNAL MEDICINE, 2001, 135 (12) :1047-1051
[6]   Clinical pharmacokinetics of atorvastatin [J].
Lennernäs, H .
CLINICAL PHARMACOKINETICS, 2003, 42 (13) :1141-1160
[7]   Drug-associated thrombotic thrombocytopenic purpura-hemolytic uremic syndrome [J].
Medina, PJ ;
Sipols, JM ;
George, JN .
CURRENT OPINION IN HEMATOLOGY, 2001, 8 (05) :286-293
[8]  
Michalets EL, 1998, PHARMACOTHERAPY, V18, P84
[9]  
Paine MF, 1997, J PHARMACOL EXP THER, V283, P1552
[10]   QUININE-INDUCED DISSEMINATED INTRAVASCULAR COAGULATION [J].
SPEARING, RL ;
HICKTON, CM ;
SIZELAND, P ;
HANNAH, A ;
BAILEY, RR .
LANCET, 1990, 336 (8730) :1535-1537